Acquisition includes Restoret, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration
This marks the first FDA approval of an AI-based brain disorder analysis solution from Korea
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
The funds raised from the Whitathon run are utilized to treat underprivileged children suffering from Retinoblastoma
The company is committed to address this observation comprehensively within stipulated time
Investing in Malaysia's largest clinic operator to expand the healthcare business
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
Subscribe To Our Newsletter & Stay Updated